Sort
64,565 grants matching “drug discovery”
cGAS inhibitors for Alzheimer's disease treatment
$847,498Subhash C Sinha · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · AG
Genetic analysis of toxinogenesis of Vibrio cholerae
$847,498John J Mekalanos · Harvard Medical School · R37 · FY2021 · AI
Genetic analysis of toxinogenesis of Vibrio cholerae
$847,498John J Mekalanos · Harvard Medical School · R37 · FY2019 · AI
Genetic analysis of toxinogenesis of Vibrio cholerae
$847,498John J Mekalanos · Harvard Medical School · R37 · FY2022 · AI
Genetic analysis of toxinogenesis of Vibrio cholerae
$847,498John J Mekalanos · Harvard Medical School · R37 · FY2023 · AI
cGAS inhibitors for Alzheimer's disease treatment
$847,498Subhash C Sinha · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · AG
cGAS inhibitors for Alzheimer's disease treatment
$847,498Li Gan · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · AG
cGAS inhibitors for Alzheimer's disease treatment
$847,498Li Gan · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · AG
Novel Network Biology Approaches to Reposition FDA-approved Drugs for Alzheimer's Disease
$847,487Bin Zhang · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · AG
Methods development for "Omics" data
$847,292Alison Motsinger-Reif · National Institute Of Environmental Health Sciences · ZIA · FY2022 · ES
Functions and Activities of p53 and Mdm2 in Normal and Cancer Cells
$847,168Carol Prives · Columbia Univ New York Morningside · R35 · FY2019 · CA
TrmD-targeting actinobacterial natural products as next generation antibiotics
$847,145Ya-Ming Hou · Thomas Jefferson University · R01 · FY2023 · AI
Personalized cancer models to discover and develop new therapeutic targets.
$847,023Christopher J Kemp · Fred Hutchinson Cancer Research Center · U01 · FY2018 · CA
NCI X-ray free electron laser (XFEL) initiative
$847,020Yun Xing M Wang · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Novel Network Biology Approaches to Reposition FDA-approved Drugs for Alzheimer's Disease
$847,014Bin Zhang · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · AG
Novel Network Biology Approaches to Reposition FDA-approved Drugs for Alzheimer's Disease
$846,972Bin Zhang · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · AG
Development of a next-generation PSD95 Inhibitor for the treatment of acute ische
$846,905Michael Tymianski · University Health Network · U01 · FY2017 · NS
BIOREPOSITORY OF HUMAN INDUCED PLURIPOTENT STEM CELLSFORCARDIOVASCULAR DISEASES (BHIPSC-CVD) - TASK AREA B
$846,862Joseph Wu · Stanford University · N01 · FY2023 · HL
Uncovering the parasite and host determinants of Plasmodium vivax hypnozoite formation and development using single cell sequencing and human liver-chimeric mice
$846,780Ashley M Vaughan · Seattle Children'S Hospital · R01 · FY2024 · AI
Signal Transduction Events and the Regulation of Cell Growth
$846,744Jane B Trepel · Division Of Clinical Sciences - Nci · ZIC · FY2015 · CA
PRO: A Protein Ontology in OBO Foundry for Integration of Biomedical Knowledge
$846,522Cathy H Wu · University Of Delaware · R01 · FY2011 · GM
Drug Discovery & Synthesis of Contraceptive Agents
$846,387Gunda I. Georg · University Of Minnesota · U01 · FY2016 · HD
The Integrative Genomics of Acute Asthma Control
$846,161Benjamin Alexander Raby · Brigham And Women'S Hospital · R01 · FY2015 · HL
Novel Network Biology Approaches to Reposition FDA-approved Drugs for Alzheimer's Disease
$845,873Bin Zhang · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · AG
High Throughput Screen for Amadorase Inhibitors
$845,835Dynamis Therapeutics, Inc. · R44 · FY2004 · DK